AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Gilead Sciences Ranks 68th in Market Activity with $1.078 Billion Trading Volume
Generated by AI AgentAinvest Volume Radar
Tuesday, Jun 3, 2025 8:08 pm ET1min read
On June 3, 2025,
(GILD) saw a trading volume of $1.078 billion, ranking 68th in the day's market activity. The stock price increased by 0.39%.Gilead's HIV franchise reported total sales of $19.6 billion in 2024, marking an 8% year-over-year increase. This growth was primarily driven by the strong performance of Biktarvy, the company's leading HIV treatment.
Analyst Michael Yee of
maintained a Buy rating on Sciences, setting a price target of $130.00. This rating reflects the company's promising pipeline and strong market position.Gilead Sciences has received a consensus Buy recommendation from analysts, with price targets ranging from $92 to $140. This positive outlook is supported by the company's extensive portfolio, which includes critical therapeutic areas such as HIV/AIDS, COVID-19, viral hepatitis, oncology, and pulmonary arterial hypertension.
Gilead Sciences is awaiting an FDA decision on Lenacapavir, an investigational twice-yearly treatment for HIV prevention. The first clinical data for Lenacapavir was presented at CROI 2025 and published in The Lancet, highlighting its potential as a groundbreaking therapy in HIV prevention.
Ainvest Volume Radar
Hunt down the stocks with explosive trading volume.
Latest Articles
Kraft Heinz Slides 1.02% as Stock Ranks 486th in Daily Trading Volume Amid Institutional Splits Earnings Woes and Dividend Strain Weigh on Investor Confidence
Dec.05 2025
AVAV's 3.15% Slide Amid 21% Volume Drop, 475th Rank Signal Earnings Optimism Fizzles
Dec.05 2025
Align Technology Extends Three-Day Rally with 0.24 Gain Ranks 452nd in $250M Turnover as Dental Sector Outperforms Peers
Dec.05 2025
PPG's 0.36% Rise Outpaces 448th-Ranked Volume as Analysts Boost Aerospace Growth Outlook
Dec.05 2025
Akamai's FedRAMP Certification Drives 31.33% Volume Surge to 445th Rank, but Stock Dips 3.59% on Investor Caution
Dec.05 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet